Skip to main content
Schizophrenia Bulletin logoLink to Schizophrenia Bulletin
. 2023 Sep 15;50(1):228–229. doi: 10.1093/schbul/sbad135

Correction to: Addressing the Evidence to Practice Gap: What to Expect From International Antipsychotic Dose Reduction Studies in the Tapering Anti-Psychotics and Evaluating Recovery Consortium

PMCID: PMC10754153  PMID: 37713624

This is a correction to: Sanne Koops, Kelly Allott, Lieuwe de Haan, Eric Chen, Christy Hui, Eoin Killackey, Maria Long, Joanna Moncrieff, Iris Sommer, Anne Emilie Stürup, Lex Wunderink, Marieke Begemann, TAPER international research consortium, Addressing the Evidence to Practice Gap: What to Expect From International Antipsychotic Dose Reduction Studies in the Tapering Anti-Psychotics and Evaluating Recovery Consortium, Schizophrenia Bulletin, 2023; sbad112, https://doi.org/10.1093/schbul/sbad112

In the originally published version of this manuscript, the final author name and the consortium name were transposed in the PDF, and the members of the consortium were not listed.

This error has been corrected online.

Collaborators: TAPER international research consortium

HAMLETT: van der A, J (Julia)1, Bakker, PR (Roberto)2,3, Beer, F (Franciska)1, Begemann, MJH1, van Beveren, NJM (Nico)4,5,6, Boonstra, TC (Nynke)7,8,9, Brand, BA (Bodyl)1, Djordjevic, M (Matej)1, Franke, S (Sigrid)1, Gangadin, SS (Shiral)1, Guloksuz, S (Sinan)2,10, Haan, L3,11, van ‘t Hag, GI (Erna)1, Hamers, I (Iris)1, van der Heijden-Hobus, IMW (Inge)1,12, Hoornaar, RJ (Joëlle)4, Huizer, K (Karin)4,13, Kikkert, MJ (Martijn)3, Koops, S1, Lokkerbol, J (Joran)14, Marcelis, M (Machteld)2,15, Oomen, PP (Priscilla)1,15, van Os, JJ (Jim)2,7,16, Rosema, BS (Bram-Sieben)1, Sommer, IEC1, Smit, F (Filip)17,18, Veling, W. (Wim)1, Voppel, AE (Alban)1; TAILOR: Albert, NA (Nikolai)19,20, Karlsen, MK (Mette Karlsen)19, Nordentoft, M (Merete)19, Speyer, H (Helene)19, Stürup, AE (Anne Emilie)19; REDUCE: Allott, K (Kelly)21,22, Killackey, E (Eóin)21,22, O’Donoghue, B (Brian)21,22, Stainton, A (Alexandra)21,22; RADAR: Cooper, RE (Ruth)23, Conneely, M (Maeve)24, Grünwald, LMG (Lisa Marie)25,26, Haynes, N (Nadia)24, Horowitz, MA (Mark)24,27, Mason, JP (John)28, Long, ML (Maria)25,29, Moncrieff, J (Joanna)25, Priebe, S (Stefan)30, Stansfeld, JL (Jacki)25, Vasiliki, G (Gkof)24; Hong Kong: Chen, EYH (Eric Yu-Hai)31, Hui, CLM (Christy Lai-Ming)31; Mesifos: Wunderink, L (Lex)1; GARMED: Liu, CC (Chen-Chung)32,33; DREAMSPHEN: Berna, F (Fabrice)34,35,36,37, Foucher, JR (Jack René)34,35,38

1Department of Psychiatry, University Medical Center Groningen (UMCG), Rijksuniversiteit Groningen (RUG), Groningen, Netherlands; 2Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, The Netherlands; 3Arkin Institute for Mental Health, Amsterdam, The Netherlands; 4Parnassia Group for Mental Health Care, Rotterdam/The Hague, The Netherlands; 5Department of Neuroscience, Erasmus MC, Rotterdam, The Netherlands; 6Department of Psychiatry, Erasmus MC, Rotterdam, The Netherlands; 7Department of Psychiatry, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, The Netherlands; 8NHL/Stenden, University of Applied Sciences, Leeuwarden, The Netherlands; 9KieN VIP Mental Health Care Services, Leeuwarden, The Netherlands; 10Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut; 11Amsterdam UMC, University of Amsterdam, Department of Psychiatry, Amsterdam, the Netherlands; 12Janssen-Cilag B.V., Breda, the Netherlands; 13Department of Pathology, Erasmus MC, Rotterdam, The Netherlands; 14Centre of Economic Evaluations & Machine Learning, Trimbos Institute, Netherlands Institute of Mental Health and Addiction, Utrecht, The Netherlands; 15Department of Research and Innovation, Institute of Mental Health Care Eindhoven (GGzE), Eindhoven, The Netherlands; 16Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, United Kingdom; 17Department of Clinical Psychology and Department of Epidemiology and Biostatistics, Amsterdam University Medical Centers, location VUmc, Amsterdam, the Netherlands; 18Department of Mental Health and Prevention, Trimbos Institute - Netherlands Institute of Mental Health and Addiction, Utrecht, The Netherlands; 19Copenhagen Research Center for Mental Health (CORE), Mental Health Center Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark; 20Center of Psychiatry Amager, Copenhagen, Denmark; 21Orygen, Melbourne, VIC, Australia; 22Centre for Youth Mental Health, University of Melbourne, Melbourne, Victoria, Australia; 23NIHR Mental Health Policy Research Unit, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK; 24North East London NHS Foundation Trust; 25Division of Psychiatry, University College London, London, UK; 26Norfolk and Suffolk NHS Foundation Trust; 27Division of Psychiatry, University College London, London, UK (Honorary); 28Barnet, Enfield and Haringey Mental Health NHS Trust; 29Department of Health Services Research and Management, City University, London, UK; 30Unit for Social and Community Psychiatry, Queen Mary University of London, London, UK; 31Department of Psychiatry, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong; 32Department of Psychiatry, National Taiwan University Hospital, Taipei, Taiwan; 33Department of Psychiatry, College of Medicine, National Taiwan University, Taipei, Taiwan; 34University of Strasbourg, Strasbourg, France; 35Department of Psychiatry, Strasbourg University Hospital, Strasbourg, France; 36Institut national de la santé et de la recherche médicale U1114, Strasbourg, France; 37Fondation FondaMental, Créteil, France; 38CNRS UMR 7357, ICube, Strasbourg, France


Articles from Schizophrenia Bulletin are provided here courtesy of Oxford University Press

RESOURCES